By:
On:
In: Fitness & Exercise, Health Insurance, Healthy Living, Heart / Cardiovascular, Mental Health, Seniors

FRIDAY, Jan. 21, 2022 (HealthDay News) — Your heart is in an incredibly vulnerable state if you’ve suffered a heart attack or are fighting heart failure, and cardiac rehabilitation could be an important part of your recovery. Unfortunately, not enough older folks appear to be taking advantage of this life-savingContinue Reading

By:
On:
In: Cancer, Gastrointestinal Problems, General Health, Health & Technology, Health Insurance

WEDNESDAY, Jan. 19, 2022 (HealthDay News) — Big surprise bills for any colonoscopy done after a positive result from a stool-based screening test will be prevented under new federal rules, a group of U.S. medical organizations say. On Jan. 10, the Biden administration issued guidance requiring private insurers to coverContinue Reading

By:
On:
In: General Health, Health & Technology, Health Insurance, Infectious Disease, Vitamins / Drugs

MONDAY, Jan. 17, 2022 (HealthDay News) — U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration andContinue Reading

By:
On:
In: Alzheimers, Health Insurance, Mental Health, Neurological, Public Health, Seniors, Vitamins / Drugs

TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading

By:
On:
In: Alzheimers, General Health, Health Insurance, Public Health, Seniors, Vitamins / Drugs

MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading

By:
On:
In: Alzheimers, Health Insurance, Mental Health, Neurological, Public Health, Seniors, Vitamins / Drugs

FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading

By:
On:
In: Cancer, General Health, Health & Technology, Health Insurance, Public Health

TUESDAY, Jan. 4, 2022 (HealthDay News) — Many insured cancer patients still experience serious money problems linked to their illness, new research affirms. For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioningContinue Reading

By:
On:
In: Alzheimers, General Health, Health Insurance, Vitamins / Drugs

MONDAY, Dec. 20, 2021 (HealthDay News) — The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022. The move follows widespread criticism of the drug’s original $56,000-a-year price tag. The reduction in the wholesaleContinue Reading